Makarov A D, Keda Iu M, Kriukova I V, Goncharov N P, Pankova S S, Komolov I S, Bazarova E N, Artemova A M, Serpukhovitin S Iu, Kozlov G I
Probl Endokrinol (Mosk). 1994 May-Jun;40(3):22-5.
Eighty patients with multinodular colloidal euthyroid goiter were examined. Thyrotropin-releasing hormone (TRH) test was carried out in 22 patients and 7 healthy women. The results of the test indicate a clear-cut tendency to reduction of hypophyseal TTH reserve in patients with multinodular euthyroid goiter with enlarged thyroid. In other words, clinical diagnosis of an euthyroid condition in the examinees appears to be groundless, particularly in patients with stage IV multinodular euthyroid goiter who may be referred to latent hyperthyrosis group on the basis of TRH test results. Three types of STH reaction were revealed by TRH test in these patients. The authors put forward a hypothesis on STH contribution as a growth factor to the pathogenesis of multinodular colloid euthyroid goiter.
对80例多结节性胶样甲状腺肿患者进行了检查。对22例患者和7名健康女性进行了促甲状腺激素释放激素(TRH)试验。试验结果表明,甲状腺肿大的多结节性胶样甲状腺肿患者垂体促甲状腺激素储备有明显降低的趋势。换句话说,受检者甲状腺功能正常的临床诊断似乎没有依据,特别是对于IV期多结节性胶样甲状腺肿患者,根据TRH试验结果,他们可能被归入潜在甲亢组。这些患者通过TRH试验揭示了三种促甲状腺激素反应类型。作者提出了关于促甲状腺激素作为生长因子在多结节性胶样甲状腺肿发病机制中的作用的假说。